Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Inhibition of ATR protein kinase activity by schisandrin B in DNA damage response.

Nishida H, Tatewaki N, Nakajima Y, Magara T, Ko KM, Hamamori Y, Konishi T.

Nucleic Acids Res. 2009 Sep;37(17):5678-89. doi: 10.1093/nar/gkp593. Epub 2009 Jul 22.

2.

Regulation of intra-S phase checkpoint by ionizing radiation (IR)-dependent and IR-independent phosphorylation of SMC3.

Luo H, Li Y, Mu JJ, Zhang J, Tonaka T, Hamamori Y, Jung SY, Wang Y, Qin J.

J Biol Chem. 2008 Jul 11;283(28):19176-83. doi: 10.1074/jbc.M802299200. Epub 2008 Apr 28.

3.
4.

Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase.

Tanaka T, Nishimura D, Wu RC, Amano M, Iso T, Kedes L, Nishida H, Kaibuchi K, Hamamori Y.

J Biol Chem. 2006 Jun 2;281(22):15320-9. Epub 2006 Mar 30.

5.

Rad GTPase attenuates vascular lesion formation by inhibition of vascular smooth muscle cell migration.

Fu M, Zhang J, Tseng YH, Cui T, Zhu X, Xiao Y, Mou Y, De Leon H, Chang MM, Hamamori Y, Kahn CR, Chen YE.

Circulation. 2005 Mar 1;111(8):1071-7. Epub 2005 Feb 14.

PMID:
15710763
6.

Nuclear hormone receptor coregulator GRIP1 suppresses, whereas SRC1A and p/CIP coactivate, by domain-specific binding of MyoD.

Wu HY, Hamamori Y, Xu J, Chang SC, Saluna T, Chang MF, O'Malley BW, Kedes L.

J Biol Chem. 2005 Feb 4;280(5):3129-37. Epub 2004 Nov 24.

7.

New cellular and molecular approaches for the treatment of cardiac disease.

Kedes L, Kloner R, Kong K, Poizat C, Simkhovich B, Iso T, Hamamori Y.

Semin Nephrol. 2004 Sep;24(5):437-40. Review.

PMID:
15490406
8.

Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure.

Sano M, Wang SC, Shirai M, Scaglia F, Xie M, Sakai S, Tanaka T, Kulkarni PA, Barger PM, Youker KA, Taffet GE, Hamamori Y, Michael LH, Craigen WJ, Schneider MD.

EMBO J. 2004 Sep 1;23(17):3559-69. Epub 2004 Aug 5.

9.

Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells.

Itoh F, Itoh S, Goumans MJ, Valdimarsdottir G, Iso T, Dotto GP, Hamamori Y, Kedes L, Kato M, ten Dijke Pt P.

EMBO J. 2004 Feb 11;23(3):541-51. Epub 2004 Jan 22.

11.

Notch signaling in vascular development.

Iso T, Hamamori Y, Kedes L.

Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):543-53. Epub 2003 Feb 13. Review.

PMID:
12615665
12.

HES and HERP families: multiple effectors of the Notch signaling pathway.

Iso T, Kedes L, Hamamori Y.

J Cell Physiol. 2003 Mar;194(3):237-55. Review.

PMID:
12548545
13.

HERP1 is a cell type-specific primary target of Notch.

Iso T, Chung G, Hamamori Y, Kedes L.

J Biol Chem. 2002 Feb 22;277(8):6598-607. Epub 2001 Dec 6.

14.

HERP, a novel heterodimer partner of HES/E(spl) in Notch signaling.

Iso T, Sartorelli V, Poizat C, Iezzi S, Wu HY, Chung G, Kedes L, Hamamori Y.

Mol Cell Biol. 2001 Sep;21(17):6080-9.

15.

HERP, a new primary target of Notch regulated by ligand binding.

Iso T, Sartorelli V, Chung G, Shichinohe T, Kedes L, Hamamori Y.

Mol Cell Biol. 2001 Sep;21(17):6071-9.

16.

Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program.

Sartorelli V, Puri PL, Hamamori Y, Ogryzko V, Chung G, Nakatani Y, Wang JY, Kedes L.

Mol Cell. 1999 Nov;4(5):725-34.

17.

A high-titer lentiviral production system mediates efficient transduction of differentiated cells including beating cardiac myocytes.

Sakoda T, Kasahara N, Hamamori Y, Kedes L.

J Mol Cell Cardiol. 1999 Nov;31(11):2037-47.

PMID:
10591030
18.

Twist is a potential oncogene that inhibits apoptosis.

Maestro R, Dei Tos AP, Hamamori Y, Krasnokutsky S, Sartorelli V, Kedes L, Doglioni C, Beach DH, Hannon GJ.

Genes Dev. 1999 Sep 1;13(17):2207-17.

19.

The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.

Bailey P, Downes M, Lau P, Harris J, Chen SL, Hamamori Y, Sartorelli V, Muscat GE.

Mol Endocrinol. 1999 Jul;13(7):1155-68.

PMID:
10406466
21.

Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A.

Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY, Nakatani Y, Kedes L.

Cell. 1999 Feb 5;96(3):405-13.

23.

Differential roles of p300 and PCAF acetyltransferases in muscle differentiation.

Puri PL, Sartorelli V, Yang XJ, Hamamori Y, Ogryzko VV, Howard BH, Kedes L, Wang JY, Graessmann A, Nakatani Y, Levrero M.

Mol Cell. 1997 Dec;1(1):35-45.

24.
25.
26.

Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.

Hamamori Y, Samal B, Tian J, Kedes L.

J Clin Invest. 1995 Apr;95(4):1808-13.

27.

Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA.

Hamamori Y, Samal B, Tian J, Kedes L.

Hum Gene Ther. 1994 Nov;5(11):1349-56.

PMID:
7893806
28.

Transforming growth factor-beta 1 potentiated alpha 1-adrenergic and stretch-induced c-fos mRNA expression in rat myocardial cells.

Miki N, Hamamori Y, Hirata K, Suematsu M, Kawashima S, Akita H, Yokoyama M.

Circ Res. 1994 Jul;75(1):8-14.

PMID:
8013086
29.

Lysophosphatidylcholine inhibits bradykinin-induced phosphoinositide hydrolysis and calcium transients in cultured bovine aortic endothelial cells.

Inoue N, Hirata K, Yamada M, Hamamori Y, Matsuda Y, Akita H, Yokoyama M.

Circ Res. 1992 Dec;71(6):1410-21.

PMID:
1330355
30.
31.
32.
33.

Inhibition of DNA synthesis by protein kinase C-activating phorbol esters in NIH/3T3 cells.

Yamamoto T, Tsuda T, Hamamori Y, Nishimura N, Takai Y.

J Biochem. 1988 Jul;104(1):53-6.

34.
36.
38.

Supplemental Content

Loading ...
Support Center